¥7,013.00
3.01% yesterday
Tokyo, Oct 31, 07:15 am CET
ISIN
JP3519400000
Symbol
4519
Index

Chugai Pharmaceutical Stock price

¥7,049.00
+601.00 9.32% 1M
-1,088.71 13.38% 6M
+119.22 1.72% YTD
-218.40 3.01% 1Y
+3,633.12 106.36% 3Y
+3,016.28 74.80% 5Y
+5,800.42 464.56% 10Y
+6,218.77 749.04% 20Y
Tokyo, Closing price Fri, Oct 31 2025
+241.00 3.54%
ISIN
JP3519400000
Symbol
4519
Index
Industry

Key metrics

Basic
Market capitalization
¥11.2t
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
29.2 | 26.3
P/S
9.2 | 9.0
EV/Sales
- | -
EV/FCF
-
P/B
-
Dividends
DPS
¥250.00
Yield 1Y | 5Y
1.4% | 1.7%
Growth 1Y | 5Y
3.1% | 12.9%
Payout 1Y | 3Y
41.2% | 38.4%
Increased
13 Years
Financials (TTM | estimate)
Revenue
¥1.2t | ¥1.2t
EBITDA
- | ¥637.3b
EBIT
¥553.2b | -
Net Income
¥397.2b | -
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
6.3% | 6.5%
EBITDA
- | 16.2%
EBIT
2.4% | -
Net Income
2.6% | -
Free Cash Flow
-
Margin (TTM | estimate)
Gross
69.5%
EBITDA
- | 51.1%
EBIT
45.6%
Net
32.7% | -
Free Cash Flow
-
Financial Health
Equity Ratio
86.1%
Return on Equity
20.4%
ROCE
-
ROIC
-
Debt/Equity
-
More
EPS
¥241.3
FCF per Share
-
Short interest
-
Employees
5k
Rev per Employee
¥232.9m
Show more

Is Chugai Pharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,030 stocks worldwide.

Chugai Pharmaceutical Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Chugai Pharmaceutical forecast:

12x Buy
60%
8x Hold
40%

Analyst Opinions

20 Analysts have issued a Chugai Pharmaceutical forecast:

Buy
60%
Hold
40%

Financial data from Chugai Pharmaceutical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1,213,713 1,213,713
6% 6%
100%
- Direct Costs 370,432 370,432
10% 10%
31%
843,281 843,281
5% 5%
69%
- Selling and Administrative Expenses 111,954 111,954
3% 3%
9%
- Research and Development Expense 187,420 187,420
10% 10%
15%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 553,227 553,227
2% 2%
46%
Net Profit 397,161 397,161
3% 3%
33%

In millions JPY.

Don't miss a Thing! We will send you all news about Chugai Pharmaceutical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of the pharmaceuticals. Its operations are carried out through the following business divisions: Research, Development, Production, Marketing, Medical Affairs and Drug Safety. The Research division focuses its efforts on creating innovative drugs by using its competitive strengths that include proprietary antibody technologies and cutting-edge research resources. The Development division provides cross-functional lifecycle management system to deliver innovative medicines to patients as quickly as possible. The Production division provides a world-class safety and quality management systems. The Marketing division conducts patient-oriented marketing activities to help solve issues related to healthcare. The Medical Affairs division works to properly deliver the value of medicines based on global compliance standards. The Drug Safety provides safety management system includes expert safety evaluation as well as timely gathering and reporting of safety information. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Osamu Okuda
Employees 5,026
Founded 1925
Website www.chugai-pharm.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today